Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline as Add-on to IFN beta-1a in RRMS
NCT01134627Phase 2Terminated
- Sponsor
- Merck KGaA
- Start
- Feb 2006
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in relapsing-remitting multiple sclerosis (RRMS), sponsored by Merck KGaA. Started Feb 2006; status: terminated.
02
Drugs
minocycline
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01134627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134627.